Electra Therapeutics
South San Francisco, US · Delaware corporation · 46 employees on LinkedIn · 4 known investors
Find your way into Electra Therapeutics
97 people in our graph share verified history with the Electra Therapeutics team — schools, employers, funds. One of them is your warm intro.
Joseph Jeongunlockedknows Adam Rosenthal · together at The Boston Consulting Group (overlapped)
×11knows the team · via The Boston Consulting Group
Electra Therapeutics develops antibody therapeutics targeting Signal Regulatory Protein (SIRP) for immunological diseases and cancer treatment. The company explores and validates novel drug targets with a focus on breakthrough therapies addressing underlying disease pathology.
Founders & leadership
AR
Adam RosenthalinCEO and Co-Founder2018–2023He founded Star Therapeutics in 2018 and co-founded its affiliated companies, including Vega Therapeutics, serving as CEO of each. Earlier, he was Chief Business Officer at True North Therapeutics, VP and Head of Corporate Development at iPierian, and a project leader at The Boston Consulting Group.
Q(
Quehuong (Kathy) Dong, Pharm.D.Executive
KD
Kathy DonginPresident, Chief Executive Officer and Director
Board
BS
Beth Seidenberg, M.D.Board director
TG
Thomas Geninatti, Ph.D.Board director
CG
Carl Gordon, Ph.D.Board director
MF
Matthew FustBoard director
NS
Nancy Stagliano, Ph.D.Board director
Investors · 4
Reported raises · per SEC filings
Form D private placements$134.2M disclosed across 1 round · 2025
▶$134.2MraisedOct 2025 · 19 investors · BiotechnologyRule 506(b)
▶$134.2MraisedOct 2025 · 19 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Beth Seidenberg, M.D.Director
- Thomas Geninatti, Ph.D.Director
- Matthew FustDirector
- Carl Gordon, Ph.D.Director
- Nancy Stagliano, Ph.D.Director
- Quehuong (Kathy) Dong, Pharm.D.Executive Officer, Director
- Offering amount
- $184.1M
- Amount sold
- $134.2M
- First sale
- Oct 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Electra18 shared keywordsElectra develops a chemistry-based iron production process powered by clean energy to produce iron at scale without environmental damage. The company serves industrial iron and steel manufacturers.
AltaThera Pharmaceuticals18 shared keywordsAltaThera develops intravenous antiarrhythmic therapies for treating cardiac conditions including atrial fibrillation and ventricular tachycardia. The company's lead product, Sotalol IV, enables faster patient assessment and potential outpatient discharge compared to oral alternatives.
Companies competing with Electra Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Venture funding drops in Seattle area as AI boom reshapes startup world – GeekWiregeekwire.com · Jul 2026Frequently asked questions
- What does Electra Therapeutics do?
- Electra Therapeutics develops antibody therapeutics targeting Signal Regulatory Protein (SIRP) for immunological diseases and cancer treatment. The company explores and validates novel drug targets with a focus on breakthrough therapies addressing underlying disease pathology.
- Who founded Electra Therapeutics?
- Electra Therapeutics was founded by Adam Rosenthal.
- Who are Electra Therapeutics's investors?
- Electra Therapeutics's investors include OrbiMed, RA Capital, Westlake Village BioPartners, NVIDIA.
- How much funding has Electra Therapeutics raised?
- Electra Therapeutics has disclosed $134.2M raised across 1 round.
- Where is Electra Therapeutics headquartered?
- Electra Therapeutics is headquartered in South San Francisco, US.